v3.20.1
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
Jan. 31, 2020
Oct. 31, 2019
Current assets:    
Cash and cash equivalents $ 2,821,882 $ 3,491,625
Short-term investments in certificates of deposit 2,870,000 2,350,000
Receivables 22,311 66,527
Prepaid expenses and other current assets 154,490 184,972
Total current assets 5,868,683 6,093,124
Property and equipment, net of accumulated depreciation of $110,013 and $95,015, respectively 201,361 200,569
Operating lease right-of-use asset 93,907
Total assets 6,163,951 6,293,693
Current liabilities:    
Accounts payable 367,098 585,817
Accrued expenses 705,034 895,498
Operating lease liability 53,384
Total current liabilities 1,125,516 1,481,315
Operating lease liability non-current 40,835
Total liabilities 1,166,351 1,481,315
Commitments and contingencies (Note 9)
Shareholders’ equity:    
Preferred stock, par value $100 per share; 19,860 shares authorized; no shares issued or outstanding, Series A convertible preferred stock, par value $100 per share; 140 shares authorized; no shares issued or outstanding
Common stock, par value $.01 per share; 48,000,000 shares authorized; 20,841,309 and 20,331,754 shares issued and outstanding, respectively 208,413 203,317
Additional paid-in capital 189,646,000 186,849,299
Accumulated deficit (184,409,806) (181,817,263)
Total shareholders’ equity 5,444,607 5,235,353
Noncontrolling interest (Note 1) (447,007) (422,975)
Total equity 4,997,600 4,812,378
Total liabilities and equity 6,163,951 6,293,693
Series A Preferred Stock [Member]    
Shareholders’ equity:    
Preferred stock, par value $100 per share; 19,860 shares authorized; no shares issued or outstanding, Series A convertible preferred stock, par value $100 per share; 140 shares authorized; no shares issued or outstanding
Preferred Stock [Member]    
Shareholders’ equity:    
Preferred stock, par value $100 per share; 19,860 shares authorized; no shares issued or outstanding, Series A convertible preferred stock, par value $100 per share; 140 shares authorized; no shares issued or outstanding

Source

v3.20.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)
3 Months Ended
Jan. 31, 2020
Jan. 31, 2019
Revenue
Operating costs and expenses:    
Amortization of patents 251,250
Research and development expenses (including non-cash share-based compensation expenses of $397,523 and $1,573,779, respectively) 1,490,588 2,247,272
General and administrative expenses (including non-cash share-based compensation expenses of $623,811 and $1,176,385, respectively) 1,139,281 2,066,456
Impairment in carrying amount of patent asset 418,750
Total operating costs and expenses 2,629,869 4,983,728
Loss from operations (2,629,869) (4,983,728)
Interest income 13,294 17,119
Loss before income taxes (2,616,575) (4,966,609)
Provision for income taxes
Net loss (2,616,575) (4,966,609)
Less: Net loss attributable to noncontrolling interest (24,032) (84,768)
Net loss attributable to common shareholders $ (2,592,543) $ (4,881,841)
Net loss per common share attributable to common shareholders:    
Basic and diluted (in Dollars per share) $ (0.13) $ (0.25)
Weighted average common shares outstanding:    
Basic and diluted (in Shares) 20,703,882 19,170,591

Source

v3.20.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
3 Months Ended
Jan. 31, 2020
Jan. 31, 2019
Cash flows from operating activities:    
Net loss $ (2,616,575) $ (4,966,609)
Stock option compensation to employees and directors 963,880 1,219,560
Stock options and warrants issued to consultants 57,454 46,219
Restricted stock award compensation to employee pursuant to stock incentive plan 1,484,385
Depreciation of property and equipment 14,998 6,130
Amortization of operating lease right-to-use asset, net of lease payments 312
Amortization of patents 251,250
Impairment in carrying amount of patent assets 418,750
Change in operating assets and liabilities:    
Receivables 44,216 203,897
Prepaid expenses and other current assets 30,482 (55,086)
Accounts payable (218,719) 30,928
Accrued expenses (190,464) 31,040
Net cash used in operating activities (1,914,416) (1,329,536)
Cash flows from investing activities:    
Disbursements to acquire short-term investments in certificates of deposit (1,870,000)
Proceeds from maturities of short-term investments in certificates of deposit 1,350,000 250,000
Purchase of property and equipment (15,790)
Net cash (used in) provided by investing activities (535,790) 250,000
Cash flows from financing activities:    
Net proceeds from sale of common stock in at-the-market offering 1,751,983 2,153,584
Proceeds from exercise of stock options 28,480 22,700
Net cash provided by financing activities 1,780,463 2,176,284
Net (decrease) increase in cash and cash equivalents (669,743) 1,096,748
Cash and cash equivalents at beginning of period 3,491,625 3,055,890
Cash and cash equivalents at end of period 2,821,882 4,152,638
Supplemental disclosure of non-cash investing and financing activities:    
Operating lease right-to-use asset (106,221)
Operating lease liability $ 106,299

Source